TORONTO -- (MARKET WIRE) -- October 31, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it will make two poster presentations of clinical data at the 6th Annual Diabetes Technology Meeting in Atlanta, Georgia, November 2 - 4, 2006. The data relates to Generex Oral-lyn™, the Company’s proprietary oral insulin spray product designed to replace prandial insulin injections, and to Generex Metformin Gum, a proprietary alternative delivery format for metformin under development by Generex in collaboration with Fertin Pharma A/S.
